Stockreport

Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Septerna, Inc.  (SEPN) 
PDF SOUTH SAN FRANCISCO, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein- [Read more]